Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Transient ischemic attacks at high altitude.

Critical Care Medicine

|May 1, 1986

Summary

Transient ischemic attacks (TIAs) at high altitude are not well understood. This study reports TIAs in climbers on Mt. Everest and suggests potential causes and treatments for these neurologic events.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effect of high altitude on the visual evoked responses in humans on Mt. Everest.

Neurosurgery·1987

Same author

Phenytoin and acute mountain sickness on Mount Everest.

The American journal of medicine·1986

Same author

Cerebral etiology of acute mountain sickness: a case report.

Neurosurgery·1985

Same author

Chlorpromazine treatment for neurogenic pulmonary edema.

Critical care medicine·1985

Same author

The role of dilantin in the prevention of pulmonary edema associated with cerebral hypoxia.

Critical care medicine·1982

Same author

High altitude cerebral edema: a pathophysiological review.

Critical care medicine·1981

Area of Science:

Neurology
Altitude Medicine
Environmental Physiology

Background:

The etiology of transient neurologic deficits at high altitude remains unclear.
High-altitude environments present unique physiological challenges.
Limited research exists on neurologic events during extreme altitude exposure.

Observation:

Two subjects experienced transient ischemic attacks (TIAs) during ascent on Mt. Everest.
A third subject reported TIAs during multiple high-altitude climbs.
These events occurred in a challenging, remote environment with limited immediate medical investigation.

Findings:

The report details clinical observations of TIAs in high-altitude climbers.
It highlights the potential for cerebrovascular events at extreme altitudes.
The study suggests possible etiologies specific to high-altitude conditions.

Implications:

Understanding TIAs at high altitude is crucial for climber safety.
Further research is needed to elucidate the pathophysiology of these events.
Developing specific treatment protocols for high-altitude TIAs may be necessary.

Related Experiment Videos